AzTrials
AzTrials

Tobacco UseSupport2QuitNCT05797155

A Mobile App Based Cognitive Dissonance Intervention for Smoking Cessation

A study testing Support2Quit App - Cognitive Dissonance Based Smoking Cessation + Smoking Cessation Tips and Tips for Smoking Cessation App in people with Tobacco Use, run by Oregon Research Behavioral Intervention Strategies, Inc. at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This research study aims to develop a cognitive dissonance-based mobile app for smoking cessation (Support2Quit) and test the efficacy of the app with 500 adult smokers who express a desire to quit smoking. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Tobacco Use
What is being tested?
Support2Quit App - Cognitive Dissonance Based Smoking Cessation + Smoking Cessation Tips and Tips for Smoking Cessation App
Could I receive a placebo?
No, everyone receives an active treatment
How many people
437 participants
Where
1 siteUnited States
Study dates
1 Dec 2023to 15 Mar 2025
Phase
Interventional
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Age 18 or older
  • Self-reported daily smoking
  • Having a valid home mailing address in the United States
  • English-speaking
  • Access to a smart phone with video capability for the duration of the project
  • Expressed desire to quit smoking

Who cannot join

  • Currently participating in a tobacco cessation program

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Oregon Research Behavioral Intervention Strategies, Inc.

    Springfield, Oregon, 97477-2019

Other trials in United States

About this study

This research study aims to develop a cognitive dissonance-based mobile app for smoking cessation (Support2Quit) and test the efficacy of the app with 500 adult smokers who express a desire to quit smoking.

Read the detailed description

This research project will evaluate the Support2Quit mobile app for smoking cessation by having 500 daily adult smokers recruited through social media and randomized to either the Support2Quit app or an app that has similar content but no tasks for inducing cognitive dissonance among participants. Outcomes will be measured at 1- and 3-months post-baseline and will include quit attempts, number of days without smoking (smoke free days), and changes in smoking attitudes and behavior, and smoking abstinence. Usability data, system log data on program use, and participant satisfaction data will also be analyzed.

The researchers hypothesize that individuals using the cognitive dissonance intervention (CDI) will show greater increases in quit attempts, smoke free days, quit rates, and positive smoking attitudes and behaviors than individuals in the active comparison condition. The researchers will test whether gender, smoking dependence, readiness to quit, previous quit attempts, age of smoking initiation, and socio-economic status moderate intervention effects on smoking outcomes.

Conditions
Tobacco Use
Being tested
Support2Quit App - Cognitive Dissonance Based Smoking Cessation + Smoking Cessation Tips, Tips for Smoking Cessation App
Medical subject headings
Tobacco Use

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Support2Quit App - Cognitive Dissonance Based Smoking Cessation + Smoking Cessation TipsBehavioural

    Support2Quit App (Cognitive Dissonance Based Smoking Cessation) Use of the Support2Quit app, completion of cognitive dissonance activities, sharing of videos with online group, and providing support to other group members

  • Tips for Smoking Cessation AppBehavioural

    App containing daily tips for smoking cessation

Study groups in NCT05797155
Study groupRoleWhat they receive
Support2Quit App - Cognitive Dissonance Based Smoking CessationExperimentalThis group will receive daily smoking cessation tips and will be asked to complete activities within the app that are designed to induce cognitive dissonance, create and share videos related to the activities with an online group, and provide support to other group members
Receives: Behavioral: Support2Quit App - Cognitive Dissonance Based Smoking Cessation + Smoking Cessation Tips
Comparison App - Smoking Cessation Support without Cognitive Dissonance ActivitiesActive comparatorThis group will use an app that consists of tips for quitting cigarettes but does not include the cognitive dissonance component.
Receives: Behavioral: Tips for Smoking Cessation App

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Number of Participants With Cigarette Abstinence

    Based on 1-item that asked "In the past 7 days, have you smoked any cigarettes?". The variable is coded 1 if they the participants indicated they did not smoke any cigarettes otherwise coded 0. A value of 1 = abstinence and 0 = not abstinent.

    Measured: 1-month and 3-month follow-up

  2. Fagerstrom Tobacco Dependence Scale

    This is a 6 item measure of tobacco dependence and response options are a mix of ordered categorical and dichotomous items. Item 1 "How many cigarettes per day to you smoke?" (0 = less than 10 cigarettes a day, 3 = 31 or more cigarettes a day). Item 2 "How soon after you wake do you smoke your first cigarette (0 = after 60 minutes, 3 = within 5 minutes). Item 3 "Is it hard to keep from smoking in places where it is prohibited (1 = yes, 0 = no). Item 4 "Which cigarette would you hate to give up most (1 = the first in the morning, 0 = any other). Item 5 "Do you smoke more cigarettes during the first 2 hours of the day compared to the rest of the day (1 = yes, 0 = no). Item 6 "Do you smoke when you are so ill you are in bed?" (1 = yes, 0 = no). A total sum score is computed and can range from 0 to 10 points with higher scores indicating higher levels of tobacco dependence.

    Measured: Baseline, 1-month follow-up, 3-month follow-up

  3. Number of Participants With Reduction in Number of Cigarettes Smoked Per Day

    Represents whether or not (1 = yes, 0 = no) a reduction of cigarettes smoked per day is reported from the baseline assessment. A higher score indicates a reduction in cigarettes smoked.

    Measured: 1-month and 3-month follow-up

  4. Number of Participants With Reduction in the Number of Cigarettes Smoked Per Day and Reduced to 0-5 Cigarettes

    Represents whether or not (1 = yes, 0 = no) a reduction of cigarettes smoked per day is reported from the baseline assessment and is the number of daily cigarettes in 0-5 per day. A higher score indicates a reduction in cigarettes smoked per day and the number smoked is 5 or less.

    Measured: 1-month and 3-month follow-up

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted4 Apr 2023
  2. Study start1 Dec 2023
  3. Primary completion15 Mar 2025
  4. Study completion15 Mar 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
This study will recruit 500 daily adult smokers through social media to test the Support2Quit app for smoking cessation. Participants will be randomly assigned to either the Support2Quit app or an app that has similar content but no tasks for inducing cognitive dissonance among participants.
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
437 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05797155
Sponsor's protocol ID
DP006495-02
Acronym
Support2Quit
Status last verified
Nov 2025
First submitted
9 Mar 2023
Last updated
24 Nov 2025
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Support2Quit App - Cognitive Dissonance Based Smoking Cessation + Smoking Cessation Tips and Tips for Smoking Cessation App in people with Tobacco Use, run by Oregon Research Behavioral Intervention Strategies, Inc. at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 24 Nov 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 24 Nov 2025). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Number of Participants With Cigarette Abstinence (time frame: 1-month and 3-month follow-up). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Nov 2025; AzTrials last refreshed its copy on 26 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in